formats

Bristol Myers and Celgene in $74bn pharmaceutical merger

Two leading US cancer drug companies announce a blockbuster tie-up valued at more than $74bn.

All rights reserved to: UIG | United Investment Group 2012 , Powered By: UCG.ae